01411nas a2200253   4500000000100000008004100001653002300042653002200065653002000087653001200107653002100119100001600140700001200156700001300168700001300181700001300194700001000207700001600217700001500233245011900248856026000367300001000627520052000637       1987                            d10aMulti-drug therapy10aleprosy treatment10aIndigenous drug10aDapsone10aNew drug regimen1 aChaudhury S1 aHazra S1 aPodder G1 aPoddar S1 aSarkar S1 aDas P1 aChaudhury S1 aMajumder V00aNew multidrug regimen with indigenous drugs and dapsone in the treatment of lepromatous leprosy preliminary report  uhttps://www.google.com/url?rct=j&sa=t&url=https://journals.lww.com/ijd/abstract/1987/32030/new_multidrug_regimen_with_indigenous_drugs_and.2.aspx&ct=ga&cd=CAEYNioUMTQ0NzE3OTA1MjUyNzkwMDYyNjUyGzdmNDU2NmU0OGFhYjA3ZGI6bmw6ZW46Tkw6TA&usg=AOvVaw23sTkAwCOlLHUa4  a63-673 a<p>Treatment of leprosy by multi-drug regimen (MDR) is not the final answer to the problem of its management. It is a transitional phase only. Need for development of new drug and new drug regimen is an urgent necessity. Present communication is a report of therapeutic assessment of a combination of active principal of two indigenous drugs plus dapsone. Preliminary report indicating that the the new drug regimen is comparable to MDR, clinically and reactional episodes are negligible in comparison to MDR.</p>